Lanaya Smith is a Rheumatologist in Baltimore, Maryland. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Mixed Connective Tissue Disease, MASS Phenotype, IgG4-Related Disease, MAGIC Syndrome, and Tissue Biopsy. Dr. Smith is currently accepting new patients.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis.

Melody Chung is a Rheumatologist in Baltimore, Maryland. Dr. Chung is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis.

Violeta Rus is a Rheumatologist in Baltimore, Maryland. Dr. Rus is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Lupus Nephritis, Systemic Lupus Erythematosus (SLE), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Rus is currently accepting new patients.

Basem Al Achras is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Al Achras has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Mixed Connective Tissue Disease, Systemic Sclerosis (SSc), and Scleroderma.

Karan Chawdhary is a Rheumatologist in Halethorpe, Maryland. Dr. Chawdhary is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Chondrocalcinosis 2, Systemic Sclerosis (SSc), and Tissue Biopsy.

Sam Serafi is a Rheumatologist in Baltimore, Maryland. Dr. Serafi is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Seema Patel is a Rheumatologist in Baltimore, Maryland. Dr. Patel has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Rheumatoid Arthritis (RA), and Discoid Lupus Erythematosus (DLE).

Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica. Dr. Hauptman is currently accepting new patients.

Tazeen Rehman is a Rheumatologist in Baltimore, Maryland. Dr. Rehman is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia.

Jazibeh Qureshi is a Rheumatologist in Baltimore, Maryland. Dr. Qureshi is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are IgG4-Related Disease, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD). Dr. Qureshi is currently accepting new patients.

Sukhpal Jassi is a primary care provider, practicing in Internal Medicine and General Practice in Glen Burnie, Maryland. Dr. Jassi is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Sitosterolemia, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Jassi is currently accepting new patients.

Joseph Nkwanyuo is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Nkwanyuo is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Mixed Connective Tissue Disease, MASS Phenotype, Familial Combined Hyperlipidemia, and Xanthoma. Dr. Nkwanyuo is currently accepting new patients.

Ikechukwu Mbonu is a Rheumatologist and a Hospital Medicine provider in Columbia, Maryland. Dr. Mbonu is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Cutaneous Lupus Erythematosus (CLE), and Rheumatoid Arthritis (RA). Dr. Mbonu is currently accepting new patients.

Iuliana Selaru is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Selaru is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are High Cholesterol, Insomnia, Sitosterolemia, and Asthma in Children. Dr. Selaru is currently accepting new patients.